Literature DB >> 25615255

Continuous renal replacement therapy in children with multiple organ dysfunction syndrome: a case series.

Yan-lin Zhang1, Wei-ping Hu1, Ling-hui Zhou1, Yin Wang1, Ao Cheng1, Si-nan Shao1, Ling-Ling Hong1, Qiu-yue Chen1.   

Abstract

There is a lack of definitive information regarding the precise indications, implementation, and outcomes of continuous renal replacement therapy (CRRT) for the treatment of critically ill children. Six children (three boys, three girls) aged from 3 days to 8 years, all of whom had multiple organ failure, were submitted to bedside CRRT using M60 filter membranes. Modified Port carbonate formula was used and clotting time was maintained between 20 and 30 minutes. Activated partial thromboplastin time was 1.5- to 2-fold normal. One patient discontinued treatment due to family decision. Marked improvements were seen in the remaining five patients, including normalization of blood urea nitrogen and creatinine levels, stabilization of electrolytes, and improvements in markers of organ function. Of note, one patient (a six-year-old male) underwent the treatment for 241 hours. All five patients were subsequently discharged and recovered uneventfully. CRRT is effective for the management of children who are critically ill due to multiple organ failure.

Entities:  

Mesh:

Year:  2014        PMID: 25615255     DOI: 10.1590/S1677-5538.IBJU.2014.06.18

Source DB:  PubMed          Journal:  Int Braz J Urol        ISSN: 1677-5538            Impact factor:   1.541


  2 in total

Review 1.  Specific Etiologies Associated With the Multiple Organ Dysfunction Syndrome in Children: Part 2.

Authors:  Jeffrey S Upperman; John C Bucuvalas; Felicia N Williams; Bruce A Cairns; Charles S Cox; Allan Doctor; Robert F Tamburro
Journal:  Pediatr Crit Care Med       Date:  2017-03       Impact factor: 3.624

2.  Outcomes of Day 1 Multiple Organ Dysfunction Syndrome in the PICU.

Authors:  Katri Typpo; R Scott Watson; Tellen D Bennett; Reid W D Farris; Michael C Spaeder; Nancy J Petersen
Journal:  Pediatr Crit Care Med       Date:  2019-10       Impact factor: 3.624

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.